Foghorn Therapeutics Inc (FHTX) Business News Jan. 13, 2026, 21:05 UTC Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium Full text
Register to leave comments News bot Jan. 13, 2026, 9:18 p.m. 📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical